PerkinElmer Acquires Project Farma, Expanding Its OneSource Professional Services Offering for the Life Sciences Industry
Summary
SHELTON, Conn.--(BUSINESS WIRE)--PerkinElmer, a global leader in analytical solutions and specialized services for (bio)pharma, applied and food markets, today announced the acquisition of Project Farma, a subsidiary of Precision for Medicine. The addition further accelerates our mission to empower customers in delivering innovative therapies to market with greater speed and efficiency.” Established in 2016, Project Farma is a patient-focused, global consultancy with a proven track record of planning, building, maintaining and retrofitting manufacturing facilities, capital expansions and technical operations in the life sciences industry. Joining PerkinElmer’s OneSource business presents an incredible opportunity to accelerate our mission of advancing next-generation medicines," said Anshul Mangal, co-founder and CEO of Project Farma. " Founded in 1937 and backed by New Mountain Capital since 2023, PerkinElmer is a global leader providing measurement, testing and sample preparation solutions, as well as specialized services for science-driven customers in (bio)pharma, applied and food markets. Powered by 5,000 passionate experts across 35 countries, we accelerate scientific breakthroughs through reliable insights, amplifying our customers impact towards a healthier, safer and more sustainable world.